Medimaging Integrated Solution Inc. (TPE:6796)
73.30
-0.70 (-0.95%)
Sep 18, 2025, 1:15 PM CST
TPE:6796 Revenue
Medimaging Integrated Solution had revenue of 154.62M TWD in the quarter ending June 30, 2025, with 26.18% growth. This brings the company's revenue in the last twelve months to 607.56M, up 23.45% year-over-year. In the year 2024, Medimaging Integrated Solution had annual revenue of 538.92M with 0.33% growth.
Revenue (ttm)
607.56M
Revenue Growth
+23.45%
P/S Ratio
4.61
Revenue / Employee
n/a
Employees
111
Market Cap
2.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 538.92M | 1.77M | 0.33% |
Dec 31, 2023 | 537.15M | 35.06M | 6.98% |
Dec 31, 2022 | 502.09M | 16.22M | 3.34% |
Dec 31, 2021 | 485.87M | 83.40M | 20.72% |
Dec 31, 2020 | 402.47M | 87.97M | 27.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |